Biology has always been an unruly science. Cells divide when they want to. Genes switch on and off like temperamental lights.

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

Dual-payload ADCs are gaining traction, offering opportunities to overcome the tumour heterogeneity and resistance challenges ...

Study highlights importance of cancer driver biology in translating results from lab to patients -- -- Findings validate proprietary OncoSLX ...

MHT CET registration link will be made active today and candidates can apply till February 12. Check the complete timeline ...

The company also announced the appointment of Han Lee, Ph.D., as co-chief executive officer (CEO), and the U.S. Food and Drug ...

Immorta Bio Inc., a scientific longevity company dedicated to Treating Diseases of Aging and Treating Aging as Disease(TM), today announced new data demonstrating that its combination therapy of ...

Illumina is building the most comprehensive multiomic solutions in the industry, anchored on its world-class sequencing ...

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious ...

Researchers have identified three previously unknown lipid molecules in rice bran, one of which strengthens the skin's ...

The peptide known as BPC‑157 (pentadecapeptide BPC-157) has garnered increasing attention across research domains ...